CLINICAL_TRIALS
trial_result
· 2025-01-22
Clinical Trial Update: A Safety and Efficacy Study of CC-90011 in Combination With Nivolumab in Subjects With Advanced Cancers [Phase 2]
Summary
Phase 2 trial results evaluating CC-90011 in combination with nivolumab in advanced cancers have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2025-01-22